A specific vitamin supplement appears to slow glaucoma-related optic nerve damage, even without lowering eye pressure. A ...

Bausch + Lomb launched a preservative-free form of Lumify redness-reducing eye drops in the U.S., according to a press ...

The FDA cleared an investigational new drug application for a phase 2 trial of GRF312 ophthalmic solution, an immunoglobulin ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

The US Food and Drug Administration (FDA) has cleared Grifols' investigational new drug (IND) application to initiate a Phase ...

BoNT-A injections may temporarily impair ocular surface stability, affecting meibomian gland function and tear film stability.

LUMIFY eye drops were initially introduced by Bausch + Lomb in 2018 and remain the only OTC redness relievers that ...

Bausch + Lomb Launches New LUMIFY® Preservative Free Redness Reliever Eye Drops in the United States ...

If you currently have eye drops in your medicine cabinet, make sure they're not part of a recent recall. Plus, how to buy ...

Nearly 76,000 cases of eye care products – including eye drops sold nationwide – have been recalled by their manufacturer. BRS Analytical Service LLC has voluntarily recalled the items ...

A team of scientists at the National Institutes of Health (NIH) has developed an eye drop that successfully slowed vision loss in mice with an inherited eye disease. In mice both with retinitis ...

The eye drops contain a small fragment derived from a protein made by the body and found in the eye, known as pigment epithelium-derived factor (PEDF). PEDF helps preserve cells in the eye's retina.